Nike is facing ongoing revenue and earnings declines, with management forecasting a high single-digit contraction through 2028 and no clear recovery in sight. Despite a current dividend yield of 4.8%, the sustainability of these payouts is uncertain as free cash flow no longer covers dividends and earnings guidance points to further pressure. The stock trades at a high valuation of 27 times 2027 earnings, even after an 81% drop from its 2021 peak. Combined with consumer spending headwinds, inflation, and macroeconomic risks, Nike's outlook remains challenging, making it a risky investment until signs of business recovery appear.
Nike's market capitalization stands at $50.25 billion as of October 5, 2026, 14:01 WIB, with a dividend yield of 4.84% on Pluang. The stock price is USD 33.93, showing a modest 0.18% increase in the last day. Despite the recent slight price uptick, the company's valuation remains high relative to its earnings outlook, reflecting ongoing challenges in its business environment.
Freedom Broker upgraded Nike shares from Sell to Buy, citing confidence in the company's long-term turnaround strategy despite weak near-term results. Nike's stock has fallen about 53% over the past year, but the new $51 price target implies a 52% up...
Nike is intentionally reducing sales volume of key products like the Dunk and Jordan lines, and pulling back from markets such as Greater China to restore brand exclusivity and pricing power. This strategy has led to a 4% revenue decline and a 5.8% d...
UBS has maintained a Neutral rating on Nike stock following the company's fiscal first-quarter revenue falling short of estimates and its announcement of layoffs. Nike's shares dropped over 7% amid weak earnings guidance and expectations of further s...
Nike's stock has dropped 75% over five years, pushing its dividend yield close to 5%, signaling market concerns. The company hopes to replicate Michael Jordan's past success by launching the Caitlin 1, its largest women's signature shoe, which sold o...
Nike shares fell below their 52-week low amid a shrinking sales outlook and challenges in China, with revenue expected to decline in fiscal 2027. Despite this, Piper Sandler analyst Abbie Zvejnieks rates Nike as Overweight with a $75 price target, im...
